MASSDEVICE ON CALL — The controversy over transvaginal mesh implants is heating up in Florida, with patient advocates calling on authorities to investigate Johnson & Johnson (NYSE:JNJ) and its leadership.
The Corporate Action Network issued an open call to Florida Attorney General Pam Bondi to probe J&J and CEO Alex Gorsky for potential misconduct related to the manufacture and sale of pelvic mesh devices.
The effort is not the group’s 1st time targeting J&J and Gorsky in particular. Earlier this year CAN launched a "Johnson & Johnson Hurts Women" website and asked for tipsters around the world to provide information that could take down the company and its executive.
"Pelvic mesh implants are perhaps the most dangerous product to women’s health on the market today," advocate organizer Jane Akre said in prepared remarks. "Gorsky should immediately pull pelvic mesh off the market, and his delay in doing so is a slap in the face to women across Florida."
The movement claims that J&J may have violated part of Deceptive & Unfair Trade Practices Act by concealing the "inherent danger" of the implants as well as for allegedly destroying important documents. The group demanded that Gorsky, who took the reins at J&J in 2012, be "held accountable for the women he has hurt."
The controversy over transvaginal mesh devices as been growing for years, gaining momentum in 2011 after the FDA issued safety communications about potential complications associated with the implants, suggesting that the devices be given a higher risk profile.
St. Jude lands innovation award for Nanostim lead-free pacemaker
St. Jude Medical (NYSE:STJ) won the Innovation Award at this year’s Cardiostim conference in Nice, France, for its tiny, leadless pacing system, Nanostim.
Augmented glasses help the clinically blind
Oxford researchers are working on a set of camera-equipped glasses that can identify objects in front of the wearer and create high-contrast renditions of the world for patients with clinical blindness.